Search results

• Finished

  Management of osteoporosis and metabolic bone disease using a marine natural product

  Long, P. (Primary Investigator), Grigoriadis, A. (Co-Investigator), Hampson, G. (Co-Investigator) & Spina, D. (Co-Investigator)

  5/01/2015 → 4/01/2016

  Project: Research

• Binding immunoglobulin protein (BiP) is a novel negative regulator of osteoclast (OC) differentiation and function

  Corrigall, V. (Primary Investigator), Grigoriadis, A. (Primary Investigator), Panayi, G. (Primary Investigator), Hampson, G. (Co-Investigator) & Henderson, B. (Co-Investigator)

  1/01/2010 → 31/12/2012

  Project: Research

• Binding immunooglobin protein (BiP) is a novel negative regulator of osteoclast differentiation and function

  Corrigall, V. (Primary Investigator), Grigoriadis, A. (Co-Investigator), Hampson, G. (Co-Investigator), Henderson, B. (Co-Investigator) & Panayi, G. (Co-Investigator)

  1/10/2009 → 30/09/2012

  Project: Research

• Potential Link Between Inhibibtory effects of bisphosphates on bone resorption and ectopic/vascular calcification in type 2 Diabetes Mellitus

  Chowienczyk, P. (Primary Investigator), Gnudi, L. (Primary Investigator) & Hampson, G. (Primary Investigator)

  1/07/2009 → 30/06/2012

  Project: Research

• Vitamin D in diabetic renal disease: VDDRD trial

  Gnudi, L. (Primary Investigator), Bilous, R. (Co-Investigator), Grieve, A. (Co-Investigator), Gulliford, M. (Co-Investigator), Hampson, G. (Co-Investigator), Karalliedde, J. (Co-Investigator), McGuire, A. (Co-Investigator) & academic, A. (Co-Investigator)

  1/04/2008 → 31/03/2013

  Project: Research

• Potential link between the inhibitory effects of bisphosphonates on bone resorption and ectopic/vascular calcification in type 0 Diabetes Mellitus

  Gnudi, L. (Primary Investigator), Hampson, G. (Primary Investigator) & Chowienczyk, P. (Co-Investigator)

  1/01/2008 → 31/12/2010

  Project: Research

• The in vivo effects of oestrogen and raloxifene on OPG/RANKL/RANK Isy peripheral mononuclear cells: an investigation of the molecular mechanism of action of these 2 agent in the prevention of bone loss and a 'novel' way of assessing treatment response.

  Hampson, G. (Primary Investigator) & Smith, A. (Co-Investigator)

  Friends of Guy's & St.Thomas' Hospital

  1/03/2003 → 29/02/2004

  Project: Research

• The role of serum osteoprotegerin determinations in the monitoring of patients receiving anti-resorptive therapy for postmenopausal osteoporosis

  Hampson, G. (Primary Investigator) & Fogelman, I. (Co-Investigator)

  National Osteoporosis Society

  1/04/2001 → 31/03/2002

  Project: Research

• To support research into chemical pathology

  Hampson, G. (Primary Investigator)

  Royal Society

  1/08/1999 → 31/07/2000

  Project: Research

• Randomised controlled trial of combination therapy using calcium/vitamin D and protein/calorie supplements in nutritionally deficient women: an assessment of changes in osteoporotic fracture risk.

  Hampson, G. (Primary Investigator)

  Action Medical Research

  1/08/1998 → 31/07/2000

  Project: Research